Your browser doesn't support javascript.
loading
Pharmacodynamic analysis of hypertension caused by lenvatinib using real-world postmarketing surveillance data.
Otani, Yuki; Kasai, Hidefumi; Tanigawara, Yusuke.
Affiliation
  • Otani Y; Department of Clinical Pharmacokinetics and Pharmacodynamics, Keio University School of Medicine, Tokyo, Japan.
  • Kasai H; Department of Clinical Pharmacokinetics and Pharmacodynamics, Keio University School of Medicine, Tokyo, Japan.
  • Tanigawara Y; Department of Clinical Pharmacokinetics and Pharmacodynamics, Keio University School of Medicine, Tokyo, Japan.
CPT Pharmacometrics Syst Pharmacol ; 10(3): 188-198, 2021 03.
Article in En | MEDLINE | ID: mdl-33471960
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Product Surveillance, Postmarketing / Quinolines / Thyroid Neoplasms / Protein Kinase Inhibitors / Hypertension Type of study: Guideline / Prognostic_studies / Screening_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: CPT Pharmacometrics Syst Pharmacol Year: 2021 Document type: Article Affiliation country: Japan Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Product Surveillance, Postmarketing / Quinolines / Thyroid Neoplasms / Protein Kinase Inhibitors / Hypertension Type of study: Guideline / Prognostic_studies / Screening_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: CPT Pharmacometrics Syst Pharmacol Year: 2021 Document type: Article Affiliation country: Japan Country of publication: United States